Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 608

Results For "RAT"

9503 News Found

ProBioGen delivers strong 2022 performance
News | April 01, 2023

ProBioGen delivers strong 2022 performance

ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.


Evonik starts construction of US$220 million lipid innovation center in Lafayette
News | March 31, 2023

Evonik starts construction of US$220 million lipid innovation center in Lafayette

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness


Lonza completes drug product manufacturing line in Visp
News | March 31, 2023

Lonza completes drug product manufacturing line in Visp

This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering


MMP Industries wins its first commercial order from Aurobindo Pharma
News | March 31, 2023

MMP Industries wins its first commercial order from Aurobindo Pharma

The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year


Abberior installs STED Microscope at MBC BioLabs
News | March 31, 2023

Abberior installs STED Microscope at MBC BioLabs

Stedycon Sted super-resolution fluorescence microscope


Granules India receives ANDA approval for Gabapentin Tablets
Drug Approval | March 30, 2023

Granules India receives ANDA approval for Gabapentin Tablets

Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults


CAHO and Dozee join hands to discuss emerging role of AI in healthcare
Digitisation | March 30, 2023

CAHO and Dozee join hands to discuss emerging role of AI in healthcare

70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai


MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
News | March 30, 2023

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers


Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
News | March 29, 2023

Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare

The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies